Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Urological Research|January 1, 1995
Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell linesY Nakajima, A DelliPizzi, C Mallouh, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 7, 2003
The eicosanoid factor: a determinant of individuality of nephron segmentsJ C McGiff, N R Ferreri, M A CarrollJournal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 28, 1998
The renal medullary thick ascending limb as a model for understanding lipid mediators in sepsisB A Escalante, I C McGiff, N R FerreriThe Prostate|November 1, 1996
TNF-mediated cytotoxicity and resistance in human prostate cancer cell linesY Nakajima, A M DelliPizzi, C Mallouh, et al.Journal of Hypertension|February 12, 1998
Tumor necrosis factor-alpha-angiotensin interactions and regulation of blood pressureN R Ferreri, Y Zhao, H Takizawa, et al.Cellular Immunology|August 1, 1992
IL-3 dependence of a Thy-1lo, B220+, IL-3 receptor-positive antigen-specific DTH-initiating cloneI Millet, N R Ferreri, R Ramabhadran, et al.Hypertension (Dallas, Tex. : 1979)|October 16, 1999
Effect of cyclooxygenase-2 inhibition on renal function after renal ablationP L Sanchez, L M Salgado, N R Ferreri, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptorsW R Herzog, N R Ferreri, W Ptak, et al.The Journal of Biological Chemistry|May 5, 1992
Molecular regulation of tumor necrosis factor-alpha and lymphotoxin production in T cells. Inhibition by prostaglandin E2N R Ferreri, T Sarr, P W Askenase, et al.Circulation Research|April 29, 2000
Cyclooxygenase-2 is required for tumor necrosis factor-alpha- and angiotensin II-mediated proliferation of vascular smooth muscle cellsW Young, K Mahboubi, A Haider, et al.Pageof 4